What does SELLAS Life Sciences Group, Inc. do?
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen;…
What is SELLAS Life Sciences Group, Inc.'s P/E and P/B ratio?
SELLAS Life Sciences Group, Inc. has a P/E ratio of -54.0 and a P/B ratio of 16.65.
What is SELLAS Life Sciences Group, Inc.'s debt-to-equity ratio?
SELLAS Life Sciences Group, Inc. has a debt-to-equity ratio of 0.01.
How much does SELLAS Life Sciences Group, Inc. owe compared with what it owns?
SELLAS Life Sciences Group, Inc. owes $0.05 for every $1 it owns (balance sheet Jun 2026), which is low.
What is SELLAS Life Sciences Group, Inc.'s Positivity rank?
SELLAS Life Sciences Group, Inc. is ranked #6,017 of 6,774 companies globally and #3,394 of 4,000 in United States on PositoAI, with a Positivity Score of 12,078.
Does SELLAS Life Sciences Group, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for SELLAS Life Sciences Group, Inc..
Where can I read the latest news about SELLAS Life Sciences Group, Inc.?
Recent headlines about SELLAS Life Sciences Group, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does SELLAS Life Sciences Group, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of SELLAS Life Sciences Group, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.